ニュースBenzingaZoetis Exec Says New U.S. Dermatology Competitor Has Had Limited Share Gains Due To Supply Challenges; Expects Third-To-/Fourth Quarter Revenue Decline In High Single-Digit Range, Partly Due To Third-quarter Promotional Activity Zoetis Exec Says New U.S. Dermatology Competitor Has Had Limited Share Gains Due To Supply Challenges; Expects Third-To-/Fourth Quarter Revenue Decline In High Single-Digit Range, Partly Due To Third-quarter Promotional Activity Benzinga 2026.11.05 14:22 (GMT+0) Benzingaで開く その他のニュース ドローン配送のZipline、評価額215億ドルに Paradigmなどがリード投資 Google、動画モデルGemini Omni 1.2 Flashを発表、コスト30%削減 OpenAI、サイバーセキュリティモデル「GPT-6 Cyber」を発表 一部顧客に先行公開 アップル、1年余りぶりに債券発行へ 約70億ドルの調達を計画 Shield AI、53億ドルでEchodyne買収へ 企業価値は288億ドルに SpaceXのCDSスプレッドが過去最高を記録
